Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032) - Concepedia

Concepedia

Publication | Closed Access

Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)

209

Citations

20

References

2011

Year

Poulam M. Patel, Stefan Suciu, Laurent Mortier, Wim H.J. Kruit, Caroline Robert, Dirk Schadendorf, Uwe Trefzer, Cornelis J.A. Punt, Reinhard Dummer, Neville Davidson,

European Journal of Cancer

Eortc 18032MedicineMelanomaPharmacotherapyCancer TreatmentStage Iv MelanomaOncologyRadiation OncologyExtended Schedule

References

	Year	Citations

Page 1

Page 1